Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Post Hoc Analysis of a Phase 3 Trial.

"Conflict of interest disclosures MJC reported grants from Hyphens Pharma, Johnson & Johnson, Kymab, LEO Pharma, L’Oréal, Perrigo, Pfizer, Regeneron Pharmaceuticals Inc., and Sanofi during the conduct of the study; personal fees from AbbVie, Astellas Pharma, Boots, Dermavant, Eli Lilly, Galapagos, Galderma, Hyphens Pharma, Johnson & Johnson, LEO Pharma, L’Oréal, Menlo Therapeutics, Novartis, Oxagen, Perrigo, Pfizer, Procter & Gamble, Reckitt Benckiser, Regeneron Pharmaceuticals Inc., and Sanofi during the conduct of the study. BL reported personal fees from AbbVie, Eli Lilly, Incyte, LEO Pharma, Pfizer, Regeneron Pharmaceuticals Inc., and Sanofi outside the submitted work; is an investigator and speaker for Eli Lilly and Regeneron Pharmaceuticals Inc.; is an investigator for Anacor Pharmaceuticals, Dermira, Franklin Bioscience, and LEO Pharma; and is an investigator, speaker, and consultant for AbbVie. AP reported payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, Almirall Hermal, Amgen, Biogen Idec, BioNTech, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Galderma, GSK, Hexal, Janssen, LEO Pharma, MC2 Pharma, Medac, Merck-Serono, Mitsubishi, MSD, Novartis, Pascoe, Pfizer, Regeneron Pharmaceuticals Inc., Roche, Sandoz, Sanofi, Schering-Plough, Tigercat Pharma, and UCB; participation in a data and safety monitoring board or advisory board for AbbVie, Almirall Hermal, Amgen, Biogen Idec, BioNTech, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Galderma, GSK, Hexal, Janssen, LEO Pharma, MC2 Pharma, Medac, Merck-Serono, Mitsubishi, MSD, Novartis, Pascoe, Pfizer, Regeneron Pharmaceuticals Inc., Roche, Sandoz, Sanofi, Schering-Plough, Tigercat Pharma, and UCB. ZC and BS are employees and shareholders of Regeneron Pharmaceuticals Inc. RS is an employee of Sanofi and may hold and/or stock options in the company."

"Sanofi and Regeneron Pharmaceuticals Inc., according to the Good Publication Practice Guidelines"